Dechra Veterinary Products
(A business unit of Dechra
Shrewsbury SY1 3TB
Tel: 01743 441632
FLEXICAM 1.5 MG/ML ORAL SUSPENSION FOR
Contra-indications, warnings, etc
Do not use in animals suffering from gastrointesti-
nal disorders, such as irritation and haemorrhage,
suspension for dogs contains 1.5 mg meloxicam as
impaired hepatic, cardiac or renal function, and
active ingredient (equivalent to 0.05 mg per drop).
haemorrhagic disorders, or where there is evidence
Alleviation of inflammation and pain in both
of individual hypersensitivity to the product.
acute and chronic musculoskeletal disorders.
Do not use in dogs less than 6 weeks of age.
Dosage and administration
If side effects occur, treatment should be discontin-
single dose of 0.2 mg meloxicam/kg body weight on
ued and the advice of a veterinarian should be sought.
the first day. Treatment is to be continued once daily
Avoid use in any dehydrated, hypovolaemic or hypo-
by oral administration (at 24 hour intervals) at a
tensive animal, as there is a potential risk of increased
maintenance dose of 0.1 mg meloxicam/kg body
Other NSAIDs, diuretics, anticoagulants, aminogly-
Shake well before use. To be administered mixed
coside antibiotics and substances with high protein
binding may compete for binding and thus lead to
The suspension can be given using either the drop
toxic effects. Flexicam must not be administered in
dispenser (for very small breeds) or the Flexicam
conjunction with other NSAIDs or glucocorticoster-
measuring syringe provided in the package.
The dispenser provides 0.05 mg Meloxicam per
Pre-treatment with anti-inflammatory substances
drop (i.e. a dose of 0.1 mg Meloxicam/kg body weight
may result in additional or increased adverse effects
corresponds to 2 drops/kg body weight). The syringe
and accordingly a treatment-free period with such
fits onto the bottle and has a kg - body weight scale
drugs should be observed for at least 24 hours before
which corresponds to the maintenance dose (i.e. 0.1
commencement of treatment. The treatment-free
mg/kg body weight). Thus, for the first day, twice the
period, however, should take into account the phar-
maintenance volume will be required.
macokinetic properties of the products used previ-
Dosing procedure using the measuring syringe:
1. Shake bottle well. Push down and unscrew bottle
In case of overdosage, symptomatic treatment
top. Attach the dosing syringe to the bottle by gently
pushing the end onto the top of the bottle.
Typical adverse drug reactions
2. Turn the bottle/syringe upside down. Pull the
of NSAIDs such as loss of appetite, vomiting, diar-
plunger out until the black line on the plunger
rhoea, faecal occult blood and apathy have occasion-
corresponds to your dog’s body weight in kilograms.
ally been reported. These side effects occur generally
3. Turn the bottle the right way up and with a
within the first treatment week and are in most cases
twisting movement, separate the dosing syringe from
transient and disappear following termination of the
treatment, but in very rare cases may be serious or
4. By pushing the plunger in, empty the contents of
If you notice any other side effects, please inform
A clinical response is normally seen within 3-4
days. Treatment should be discontinued after 10 days
People with known hypersen-
at the latest if no clinical improvement is apparent.
sitivity to NSAIDs should avoid contact with the
Avoid introduction of contamination during use.
Particular care should be taken with regard to the
In case of accidental ingestion, seek medical advice
accuracy of dosing. Please carefully follow the in-
immediately and show the package insert or label to
For animal treatment only.
ing 10 ml, 32 ml or 100 ml with a polyethylene
dropper, a tamper-proof child resistant closure and a
Do not use after the expiry date stated on the carton
Shelf life of opened bottle: 9 months.
Services UK Limited, Langhurstwood Road, Hor-
Any unused product or waste material
derived from such veterinary medicinal productsshould be disposed of in accordance with local
Marketing authorisation number
Approved datasheets found:
30/9/2008 14:24:24 (UK)
Approved for book but not on website:
Datasheets marked as draft (ignored):
Services Provided We focus on weaning, stabilizing, and rehabilitating the patient who would otherwise receive traditional hospital care. www.foxsubacute.com Ventilator patients: Weaning or Chronic Medically stable patients requiring ventilation; each patient assessed for an individual Patients requiring full or nocturnal ventilatory support-that have a prognosis for we
Post-Operative Instructions for (Low Back) Lumbar Spine Surgery Laminectomy, Discectomy, Spinal Fusion We want to make this experience as pleasant as possible for you and your family. If you have any questions before or after your surgery, please contact our office at 303-697-7463. PLEASE NOTE THAT IN SOME CASES, DUE TO UNFORESEEN EVENTS INCLUDING EMERGE